FXN and Friedreich ataxia: For this reason, we first transduced OE-MSCs derived from a FRDA patient with the Lv-FXN I (Figure 1A) or the Lv-FXN II (Figure 1B) for 48 h, which allowed us to obtain a frataxin expression level of 200–400% when compared to untreated cells.